I promise

"I promise, Suzy... Even if it takes the rest of my life." - Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is Triple Negative Breast Cancer?


Just in recent years, Triple Negative Breast Cancer has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" type of cancer. Being Triple Negative, you don't have a targeted therapy and that your only treatment option is chemotherapy.

Triple Negative is seen in about 15% of all breast cancers. Triple Negative is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TN is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Wednesday, September 27, 2017

NW Ohio Komen Race for the Cure 2017

Proud supporter of Komen, NW Ohio -Melissa
12,000 people participated in the 24th Annual Komen Race for the Cure in Downtown Toledo on September 24, 2017.  Thank You Northwest Ohio for your support and donations that help uninsured/underinsured women in breast health services and for breast cancer research.  As an 8 year breast cancer survivor myself and my bond with many other breast cancer survivors across our nation, I truly do appreciate everyones support in helping reducing the lives lost to breast cancer. 
Close to 94% of patients living with metastatic breast cancer were previously treated for an earlier stage of breast cancer.
Susan G. Komen has announced $31 million in 2017 research grant funding focusing on metastatic breast cancer including:

  •  Advance in understanding on how and why breast cancer spreads, and how to treat or prevent metastasis 
  • New treatments of targeted therapies and drug developments for aggressive types of breast cancer, including TNBC
  • Why drug resistance occurs in breast cancer patients and how to overcome it
  • Disparities in breast cancer outcomes
  • Funding young investigators in breast cancer research 


Thank you Northwest Ohio Komen participants and spectators
for your continued support of us breast cancer survivors!

All of us survivors in pink!

Triple Negative Breast Cancer sisters, Melissa and Genny

Our supporters!

In Celebration of Melissa Paskvan
Survivor Champion 8 years!

Pink sisters Melissa and Joyce
with our froggie fan!

Triple Negative Breast Cancer sisters,
Melissa P. and Melissa J. with cancer researcher,
Dr. Amit Tiwari

Pink Ribbon survivors!

Total Pageviews

Click to help fund mammograms for the uninsured

The Breast Cancer Site

Triple Negative Breast Cancer Foundation

Triple Negative Breast Cancer Foundation
"click image to link"

"Click image to link"